This week in PLoS Medicine: HIV resistance in women treated with nevirapine; Charging less for more effective treatments; Developing guidelines for better reporting

Read the new papers published in PLoS Medicine this week, including a Research Article that confirms that a single dose of nevirapine (sdNVP) can lead to HIV treatment failure in women, another Research Article that calculates the benefits of value-based insurance design, in which patients pay less for highly cost-effective services, and a Guidelines and Guidance piece that provides a substantial new resource for the developers of guidelines of the reporting of health research.

You can comment on, annotate, and rate this week’s PLoS Medicine articles and any of the others in the archive.

This entry was posted in General and tagged , , , , , , , . Bookmark the permalink.

Comments are closed.